Sepideh Izadi

1.2k total citations · 1 hit paper
20 papers, 686 citations indexed

About

Sepideh Izadi is a scholar working on Molecular Biology, Biomedical Engineering and Oncology. According to data from OpenAlex, Sepideh Izadi has authored 20 papers receiving a total of 686 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Biomedical Engineering and 5 papers in Oncology. Recurrent topics in Sepideh Izadi's work include Nanoplatforms for cancer theranostics (5 papers), Adenosine and Purinergic Signaling (4 papers) and RNA Interference and Gene Delivery (3 papers). Sepideh Izadi is often cited by papers focused on Nanoplatforms for cancer theranostics (5 papers), Adenosine and Purinergic Signaling (4 papers) and RNA Interference and Gene Delivery (3 papers). Sepideh Izadi collaborates with scholars based in Iran, Germany and Sweden. Sepideh Izadi's co-authors include Yashwant Pathak, Mostafa Jarahian, Max Stanley Chartrand, Faroogh Marofi, Alexei Valerievich Yumashev, Navid Shomali, Safa Tahmasebi, В. А. Сафонов, Ali Hassanzadeh and Naghmeh Shirafkan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nano Letters and Small.

In The Last Decade

Sepideh Izadi

17 papers receiving 675 citations

Hit Papers

CAR T cells in solid tumors: challenges and opportunities 2021 2026 2022 2024 2021 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sepideh Izadi Iran 10 401 240 228 188 87 20 686
James W. Opzoomer United Kingdom 8 370 0.9× 329 1.4× 275 1.2× 171 0.9× 62 0.7× 11 828
Mahboubeh Yazdanifar United States 17 624 1.6× 307 1.3× 448 2.0× 168 0.9× 115 1.3× 29 988
Noor Jailkhani United States 10 330 0.8× 355 1.5× 222 1.0× 137 0.7× 72 0.8× 15 747
Meena Kadapakkam United States 6 530 1.3× 274 1.1× 190 0.8× 260 1.4× 136 1.6× 7 847
Patrick C. Gedeon United States 15 516 1.3× 213 0.9× 282 1.2× 167 0.9× 105 1.2× 29 768
Sarah Nietzer Germany 11 344 0.9× 162 0.7× 115 0.5× 213 1.1× 50 0.6× 20 604
Μαρκέλλα Ζαννίκου United States 10 203 0.5× 262 1.1× 228 1.0× 165 0.9× 41 0.5× 14 635
Ali Hassanzadeh Iran 7 360 0.9× 158 0.7× 189 0.8× 140 0.7× 87 1.0× 12 543
Yogindra Vedvyas United States 14 488 1.2× 180 0.8× 205 0.9× 204 1.1× 111 1.3× 25 692

Countries citing papers authored by Sepideh Izadi

Since Specialization
Citations

This map shows the geographic impact of Sepideh Izadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sepideh Izadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sepideh Izadi more than expected).

Fields of papers citing papers by Sepideh Izadi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sepideh Izadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sepideh Izadi. The network helps show where Sepideh Izadi may publish in the future.

Co-authorship network of co-authors of Sepideh Izadi

This figure shows the co-authorship network connecting the top 25 collaborators of Sepideh Izadi. A scholar is included among the top collaborators of Sepideh Izadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sepideh Izadi. Sepideh Izadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Masjedi, Ali, Sepideh Izadi, Vahid Karpisheh, et al.. (2025). Advancing the therapeutic effectiveness of paclitaxel in chronic lymphocytic leukemia through the simultaneous inhibition of NOTCH1 and SF3B1. Cancer Cell International. 25(1). 104–104.
2.
Nezafat, Negin Beryani, Sepideh Izadi, Inga Ennen, et al.. (2025). Dephasing Mechanisms of Topologically Protected 2D Surface Carriers in Sputtered SnTe Thin Films. Nano Letters. 25(31). 11811–11818. 1 indexed citations
3.
Pourentezari, Majid, et al.. (2024). Production of Cartilaginous Organoids: Potential Opportunities and Challenges, A Review Article.. SHILAP Revista de lepidopterología. 26(7). 427–435.
4.
5.
Karpisheh, Vahid, Ali Masjedi, Sepideh Izadi, et al.. (2023). Targeted Silencing of NRF2 by rituximab-conjugated nanoparticles increases the sensitivity of chronic lymphoblastic leukemia cells to Cyclophosphamide. Cell Communication and Signaling. 21(1). 188–188. 9 indexed citations
6.
Izadi, Sepideh, Jeong Woo Han, Ulrike Wolff, et al.. (2023). Density‐Dependence of Surface Transport in Tellurium‐Enriched Nanograined Bulk Bi2Te3. Small. 19(11). e2204850–e2204850. 7 indexed citations
7.
Kiaie, Seyed Hossein, et al.. (2022). Extended-release of doxorubicin through green surface modification of gold nanoparticles: in vitro and in ovo assessment. BMC Chemistry. 16(1). 110–110. 9 indexed citations
8.
Masjedi, Ali, Vahid Karpisheh, Sepideh Izadi, et al.. (2022). Combined inhibition of EZH2 and CD73 molecules by folic acid-conjugated SPION-TMC nanocarriers loaded with siRNA molecules prevents TNBC progression and restores anti-tumor responses. Life Sciences. 309. 121008–121008. 10 indexed citations
9.
Karpisheh, Vahid, Ali Masjedi, Sepideh Izadi, et al.. (2022). Increased susceptibility to doxorubicin-induced cell death in acute lymphocytic leukemia cells by inhibiting serine/threonine WEE1 kinase expression using the chitosan-carboxymethyl dextran-polyethylene glycol-TAT nanoparticles. Journal of Drug Delivery Science and Technology. 77. 103868–103868. 9 indexed citations
10.
Hajizadeh, Farnaz, Angelina Olegovna Zekiy, Ali Masjedi, et al.. (2021). Simultaneous inhibition of CD73 and IL-6 molecules by siRNA-loaded nanoparticles prevents the growth and spread of cancer. Nanomedicine Nanotechnology Biology and Medicine. 34. 102384–102384. 17 indexed citations
11.
Izadi, Sepideh, Vahid Karpisheh, Hadi Hassannia, et al.. (2021). Simultaneous blockade of TIGIT and HIF-1α induces synergistic anti-tumor effect and decreases the growth and development of cancer cells. International Immunopharmacology. 101(Pt A). 108288–108288. 30 indexed citations
12.
Marofi, Faroogh, Roza Motavalli, В. А. Сафонов, et al.. (2021). CAR T cells in solid tumors: challenges and opportunities. Stem Cell Research & Therapy. 12(1). 81–81. 395 indexed citations breakdown →
13.
Budi, Hendrik Setia, Sepideh Izadi, Anton Timoshin, et al.. (2021). Blockade of HIF-1α and STAT3 by hyaluronate-conjugated TAT-chitosan-SPION nanoparticles loaded with siRNA molecules prevents tumor growth. Nanomedicine Nanotechnology Biology and Medicine. 34. 102373–102373. 25 indexed citations
14.
Izadi, Sepideh, Jeong Woo Han, Ulrike Wolff, et al.. (2021). Interface‐Dominated Topological Transport in Nanograined Bulk Bi2Te3. Small. 17(42). e2103281–e2103281. 14 indexed citations
15.
Izadi, Sepideh, Afshin Nikkhoo, Mohammad Hojjat‐Farsangi, et al.. (2020). CDK1 in Breast Cancer: Implications for Theranostic Potential. Anti-Cancer Agents in Medicinal Chemistry. 20(7). 758–767. 67 indexed citations
16.
Hashemibeni, Batool, Majid Pourentezari, Ali Valiani, et al.. (2020). Impact of Fibrin on the Chondrogenic Avocado Soybean Unsaponifiables on Poly (Lactic-co-Glycolic) Acid Scaffold. Biointerface Research in Applied Chemistry. 11(4). 11525–11534. 1 indexed citations
17.
Hajizadeh, Farnaz, Ali Masjedi, Sepideh Izadi, et al.. (2020). Combined inhibition of CD73 and ZEB1 by Arg-Gly-Asp (RGD)-targeted nanoparticles inhibits tumor growth. Colloids and Surfaces B Biointerfaces. 197. 111421–111421. 21 indexed citations
18.
Hajizadeh, Farnaz, Ali Masjedi, Fatemeh Atyabi, et al.. (2020). Silencing of HIF-1α/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progression. European Journal of Pharmacology. 882. 173235–173235. 55 indexed citations
19.
Izadi, Sepideh, Georg Bendt, Jörg Sundermeyer, et al.. (2020). Ionic Liquid-Based Low-Temperature Synthesis of Phase-Pure Tetradymite-Type Materials and Their Thermoelectric Properties. Inorganic Chemistry. 59(6). 3428–3436. 11 indexed citations
20.
Izadi, Sepideh, et al.. (2018). Investigating surface morphology of Ag-AgCl thin film by scattering pattern at normal and oblique incident angles. Applied Optics. 57(36). 10355–10355. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026